检验医学 ›› 2017, Vol. 32 ›› Issue (2): 90-93.DOI: 10.3969/j.issn.1673-8640.2017.02.005

• 临床应用研究·论著 • 上一篇    下一篇

慢性阻塞性肺疾病患者血清甘胆酸、C反应蛋白与肺、肝功能改变的相关性研究

晏峰, 周颖, 徐伟珍   

  1. 丽水市人民医院检验科,浙江 丽水 323000
  • 收稿日期:2016-04-05 出版日期:2017-03-30 发布日期:2017-03-30
  • 作者简介:null

    作者简介:晏 峰,男,1975年生,硕士,副主任技师,主要从事临床生化检验工作。

Correlations of serum cholyglycine and C-reactive protein with the altering of lung and liver function in patients with chronic obstructive pulmonary disease

YAN Feng, ZHOU Ying, XU Weizhen   

  1. Department of Clinical Laboratory,Lishui City People's Hospital,Lishui 323000,Zhejiang,China
  • Received:2016-04-05 Online:2017-03-30 Published:2017-03-30

摘要:

目的 通过检测慢性阻塞性肺疾病(COPD)患者血清甘胆酸(CG)与C反应蛋白(CRP)水平变化,探讨CG、CRP与肺、肝功能改变的相关性。方法 选取64例COPD患者,其中慢性阻塞性肺疾病急性加重期(AECOPD)46例(32例合并肝损伤,14例未合并肝损伤)、稳定期18例;以健康体检者27名作为正常对照组。分别测定COPD组治疗前肝功能[谷氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆红素(TB)、直接胆红素(DBil)和白蛋白(Alb)] CG、CRP水平及治疗后血清CG、CRP水平,同时测定正常对照组血清CG、CRP水平。结果 COPD组血清CG、CRP水平明显高于正常对照组(P<0.05),AECOPD组血清CG、CRP水平高于稳定期组(P<0.05),AECOPD组合并肝损伤组CG、CRP水平高于AECOPD未合并肝损伤组(P<0.05)。COPD组治疗前血清CG、CRP阳性率分别为82.8%、85.9%,治疗后分别为28.1%、21.9%,较治疗前明显降低(P<0.05)。治疗前,AECOPD合并肝损伤组ALT、AST和CG水平均高于AECOPD未合并肝损伤组及稳定期组(P<0.01); AECOPD未合并肝损伤组ALT和CG水平均明显高于稳定期组(P<0.05);AECOPD合并肝损伤组及未合并肝损伤组TB、DBil和Alb水平差异均无统计学意义(P>0.05)。在反映肝功能损伤方面,CG阳性率最高,ALT次之,AST最低。COPD患者血清CG与ALT、AST、CRP均呈正相关(r值分别为0.653、0.532、0.783,P<0.01),与Alb、TB、DBil无相关性(r值分别为0.208、0.252、0.267,P>0.05)。结论 CG和CRP均参与了COPD的急性炎症过程。COPD患者肺损伤的同时肝脏也有不同程度的损伤。

关键词: Cholyglycine, C-reactive protein, Chronic obstructive pulmonary disease, Liver damage

Abstract:

Objective To determine the level changes of serum cholyglycine(CG) and C-reactive protein(CRP) in patients with chronic obstructive pulmonary disease(COPD),and to investigate the correlations with the altering of lung and liver function.Methods A total of 64 patients with COPD were enrolled and classified into acute exacerbation of chronic obstructive pulmonary disease(AECOPD) group(46 cases,including 32 cases with liver damage and 14 cases without liver damage) and stable COPD group(18 cases). A total of 27 healthy subjects were enrolled as healthy control group. The levels of serum CG and CRP were determined before and after treatment. Alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TB),direct bilirubin(DBil)and albumin(Alb) in COPD group were determined before treatment.Results Serum CG and CRP in COPD group were higher than those in healthy control group(P<0.05). In AECOPD group,serum CG and CRP were higher than those in stable COPD group(P<0.05). In AECOPD with liver damage group,serum CG and CRP were higher than those in AECOPD without liver damage group(P<0.05). The positive rates of serum CG and CRP in COPD group before treatment were 82.8% and 85.9%,and those after treatment were 28.1% and 21.9%(P<0.05). The levels of ALT,AST and serum CG in AECOPD with liver damage group were higher than those in AECOPD without liver damage group and stable COPD group(P<0.01). The levels of ALT and serum CG in AECOPD group without liver damage were higher than those in stable COPD group(P<0.05). The levels of TB,DBil and Alb in AECOPD with and without liver damage groups had no statistical significance(P>0.05). The positive rate of serum CG was the highest,followed by those of ALT and AST. There was a positive correlation of serum CG with ALT,AST and CRP(r=0.653,0.532 and 0.783,P<0.01), but there was no correlation with Alb,TB and DBil(r= 0.208,0.252 and 0.267,P>0.05). Conclusions Serum CG and CRP are involved in acute inflammatory process of COPD. For patients with COPD,there exists lung damage,while there are different degrees of liver damage.

Key words: Cholyglycine, C-reactive protein, Chronic obstructive pulmonary disease, Liver damage

中图分类号: